Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Related Content

Genetic Engineering. The study of the structure of DNA and RNA, the introduction of changes at the gene level. Modern medical research of stem cells. 3D illustrations | Image Credit: © Siarhei - © Siarhei - stock.adobe.com

FDA Designation and UK Approval for AAVB-039 Highlight Progress in Complex Gene Therapy Development

ByFeliza Mirasol

October 2nd 2025

Doctor technology AI integrates big data analytics with clinical research, enabling precise treatment plans tailored to individual patient needs and genetic profiles. | Image Credit: © Suriyo - © Suriyo - stock.adobe.com

New FDA Guidance Utilizes Real-World Data and AI for Postmarket CGT Surveillance

ByFeliza Mirasol

October 1st 2025

Young woman with genetic research in the laboratory research of cancer diseases | Image Credit: © luchschenF - © luchschenF - stock.adobe.com

Implications of FDA’s New Draft Guidance on Innovative Trial Design for Rare-Disease CGTs

ByFeliza Mirasol

September 30th 2025

Double helix DNA molecule with modified genes , Correcting mutation by genetic engineering | Image Credit: © nobeastsofierce - stock.adobe.com

New FDA RMAT Guidance's Impact on Clinical, CMC Strategies

ByPatrick Lavery

September 29th 2025

How 100% Pharmaceutical Tariffs Will Impact Domestic Manufacturing and Supply Chains

100% Pharmaceutical Tariff Will Reshape US Biopharm Manufacturing Supply Chains

ByChristopher Cole

September 26th 2025

Resources, Guidelines, and Guidance Documents

Articles in this issue

Newsletter

Related Content

FDA Designation and UK Approval for AAVB-039 Highlight Progress in Complex Gene Therapy Development

New FDA Guidance Utilizes Real-World Data and AI for Postmarket CGT Surveillance

Implications of FDA’s New Draft Guidance on Innovative Trial Design for Rare-Disease CGTs

New FDA RMAT Guidance's Impact on Clinical, CMC Strategies

100% Pharmaceutical Tariff Will Reshape US Biopharm Manufacturing Supply Chains

Trending on BioPharm International

Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs

Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms

How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia

Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care

Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care